We're delighted to add our latest Educational Series titled: Managing Cardiovascular Risk in Patients with Prostate Cancer Requiring Androgen Deprivation Therapy. This Educational Review presents recommendations for cardiovascular risk assessment and management in men with prostate cancer receiving ADT, including specific recommendations regarding choice of ADT.
It also includes guiding commentary from Professor Henry Woo, Head of the Department of Urology at Blacktown Hospital and Director of Uro-Oncology at the Chris O’Brien Lifehouse. He is a Conjoint Professor at the Western Sydney University and Honorary Professor at the Australian National University.
Please login below to download this issue (PDF)